98 related articles for article (PubMed ID: 414992)
1. The binding of adjuvant-active mycobacterial peptidoglycolipids and glycopeptides to mammalian membranes and their effect on artificial lipid bilayers.
Stewart-Tull DE; Davies M; Jackson DM
Immunology; 1978 Jan; 34(1):57-67. PubMed ID: 414992
[TBL] [Abstract][Full Text] [Related]
2. The dissociation of adjuvant properties of mycobacterial components from mitogenicity, and from the ability to induce the release of mediators from macrophages.
Rook GA; Stewart-Tull DE
Immunology; 1976 Sep; 31(3):389-96. PubMed ID: 800406
[TBL] [Abstract][Full Text] [Related]
3. The dual affinity of a mycobacterial glycopeptide for sheep erythrocyte membranes and guinea-pig gamma-globulin.
Davies M; Stewart-Tull DE
Immunology; 1973 Jul; 25(1):1-9. PubMed ID: 4124706
[TBL] [Abstract][Full Text] [Related]
4. The cell surface-exposed glycopeptidolipids confer a selective advantage to the smooth variants of Mycobacterium smegmatis in vitro.
Kocíncová D; Winter N; Euphrasie D; Daffé M; Reyrat JM; Etienne G
FEMS Microbiol Lett; 2009 Jan; 290(1):39-44. PubMed ID: 19025562
[TBL] [Abstract][Full Text] [Related]
5. [Liposome interaction with cells. Liposomes with a liquid-crystal membrane].
Margolis LB; Neĭfakh AA
Usp Sovrem Biol; 1982; 93(2):214-29. PubMed ID: 7048783
[No Abstract] [Full Text] [Related]
6. Potassium, magnesium and membranes. Review of present status and new findings.
Bara M; Guiet-Bara A
Magnesium; 1984; 3(4-6):215-25. PubMed ID: 6399343
[TBL] [Abstract][Full Text] [Related]
7. [Plasma lipoproteins, modifiers of the ionic permeability of artificial lipid membranes].
Tverdislov VA; El' Karadagi S; Martseniuk OV; Gerasimova EN
Biofizika; 1980; 25(5):841-7. PubMed ID: 7191329
[TBL] [Abstract][Full Text] [Related]
8. [Membranotropic effect of phosphocreatine and its structural analogs].
Konorev EA; Medvedeva NV; Dzhaliashvili IV; Stepanov VA; Saks VA
Biokhimiia; 1991 Sep; 56(9):1701-9. PubMed ID: 1660733
[TBL] [Abstract][Full Text] [Related]
9. Cellular responsiveness in vitro: the effect of mycobacterial glycopeptides, glycolipids and peptidoglycolipids on the in vitro growth of haemopoietic colony-forming cells.
Fleming WA; Stewart-Tull DE; McClure S; McKee AM
Immunology; 1984 Mar; 51(3):555-61. PubMed ID: 6607876
[TBL] [Abstract][Full Text] [Related]
10. [Relation between lipid fraction and adjuvant activity of waxes D, peptido-glycolipids, of Mycobacterium tuberculosis].
Hiu IJ; Amiel JL; Jolles P
Rev Fr Etud Clin Biol; 1969 May; 14(5):508-10. PubMed ID: 4240664
[No Abstract] [Full Text] [Related]
11. Mycobacteria glycolipids as potential pathogenicity effectors: alteration of model and natural membranes.
Sut A; Sirugue S; Sixou S; Lakhdar-Ghazal F; Tocanne JF; Lanéelle G
Biochemistry; 1990 Sep; 29(36):8498-502. PubMed ID: 2123718
[TBL] [Abstract][Full Text] [Related]
12. Peptide helicity and membrane surface charge modulate the balance of electrostatic and hydrophobic interactions with lipid bilayers and biological membranes.
Dathe M; Schümann M; Wieprecht T; Winkler A; Beyermann M; Krause E; Matsuzaki K; Murase O; Bienert M
Biochemistry; 1996 Sep; 35(38):12612-22. PubMed ID: 8823199
[TBL] [Abstract][Full Text] [Related]
13. [Interaction of enkephalin with lipid components of cell membranes].
Gabrielian ES; Badzhinian SA; Alaverdian KG
Biull Eksp Biol Med; 1983 Jul; 96(7):65-7. PubMed ID: 6871457
[TBL] [Abstract][Full Text] [Related]
14. [Oxytocin interaction with lipids of artificial and biological membranes].
Rybal'chenko VK; Ostrovskaia GV; Kucherenko NE
Biull Eksp Biol Med; 1989 Dec; 108(12):681-3. PubMed ID: 2534504
[TBL] [Abstract][Full Text] [Related]
15. [Binding of voltaren and piroxicam with the membranes of erythrocyte ghosts and liposomes].
Mogilevich SE; Kul'chitskiĭ G; Klebnov BM
Farmakol Toksikol; 1988; 51(4):87-90. PubMed ID: 3191984
[TBL] [Abstract][Full Text] [Related]
16. Toxin interactions with glycoconjugates.
Wiegandt H
Adv Cytopharmacol; 1979; 3():17-25. PubMed ID: 382782
[No Abstract] [Full Text] [Related]
17. Sapporo cancer seminar: membrane-associated alterations in cancer--biochemical strategies against cancer.
Black PH; Hakomori S; Warren L
Cancer Res; 1983 May; 43(5):2322-3. PubMed ID: 6831456
[No Abstract] [Full Text] [Related]
18. Immunological adjuvants. 3. A preliminary report about the mode of action of mycobacterial adjuvants and further confirmation of adjuvant activity of acetylated wax D.
Koga T; Ishibashi T; Sugiyama K; Tanaka A
Int Arch Allergy Appl Immunol; 1969; 36(3):233-44. PubMed ID: 4982193
[No Abstract] [Full Text] [Related]
19. Immunological adjuvants. II. Immunological activities of an adjuvant-active mycobacterial lipid, wax D, in the form of aqueous suspension.
Shinozaki S; Tanaka A; Sugiyama K
Int Arch Allergy Appl Immunol; 1969; 35(4):313-22. PubMed ID: 4976510
[No Abstract] [Full Text] [Related]
20. Identification of the physiologically active state of the mycobacterial glycolipid trehalose 6,6'-dimycolate and the role of fibrinogen in the biologic activities of trehalose 6,6'-dimycolate monolayers.
Retzinger GS; Meredith SC; Hunter RL; Takayama K; Kézdy FJ
J Immunol; 1982 Aug; 129(2):735-44. PubMed ID: 6806381
[No Abstract] [Full Text] [Related]
[Next] [New Search]
